[1]
Baran, S.W., Brown, P.C., Baudy, A.R., Fitzpatrick, S.C., Frantz, C., Fullerton, A., Gan, J., Hardwick, R.N., Hillgren, K.M., Kopec, A.K., Liras, J.L., Mendrick, D.L. , Nagao, R., Proctor, W.R. , Ramsden, D., Ribeiro, A.J.S., Stresser, D., Sung, K.E. , Sura, R., Tetsuka, K., Tomlinson, L., Van Vleet, T., Wagoner, M.P. , Wang, Q., Arslan, S.Y. , Yoder, G. and Ekert, J.E. 2022. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate). ALTEX - Alternatives to animal experimentation. 39, 2 (Apr. 2022), 297–314. DOI:https://doi.org/10.14573/altex.2112203.